Modulation of in vitro proliferation kinetics and primitive hematopoietic potential of individual human CD34+CD38-/lo cells in G0

Edward Srour, Xia Tong, Woong Sung Ki, P. Artur Plett, Susan Rice, Joanne Daggy, Constantin Yiannoutsos, Rafat Abonour, Christie Orschell

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Whether cytokines can modulate the fate of primitive hematopoietic progenitor cells (HPCs) through successive in vitro cell divisions has not been established. Single human marrow CD34+CD38-/lo cells in the G0 phase of cell cycle were cultured under 7 different cytokine combinations, monitored for proliferation on days 3, 5, and 7, then assayed for long-term culture-initiating cell (LTC-IC) function on day 7. LTC-IC function was then retrospectively correlated with prior number of in vitro cell divisions to determine whether maintenance of LTC-IC function after in vitro cell division is dependent on cytokine exposure. In the presence of proliferation progression signals, initial cell division was independent of cytokine stimulation, suggesting that entry of primitive HPCs into the cell cycle is a stochastic property. However, kinetics of proliferation beyond day 3 and maintenance of LTC-IC function were sensitive to cytokine stimulation, such that LTC-IC underwent an initial long cell cycle, followed by more synchronized shorter cycles varying in length depending on the cytokine combination. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) transplantation studies revealed analogous results to those obtained with LTC-ICs. These data suggest that although exit from quiescence and commitment to proliferation might be stochastic, kinetics of proliferation, and possibly fate of primitive HPCs, might be modulated by extrinsic factors.

Original languageEnglish
Pages (from-to)3109-3116
Number of pages8
JournalBlood
Volume105
Issue number8
DOIs
StatePublished - Apr 15 2005

Fingerprint

Cells
Modulation
Cell culture
Cytokines
Cell Culture Techniques
Cell Division
Kinetics
Hematopoietic Stem Cells
Cell Cycle
Maintenance
Severe Combined Immunodeficiency
Cell Cycle Resting Phase
In Vitro Techniques
Transplantation
Bone Marrow

ASJC Scopus subject areas

  • Hematology

Cite this

Modulation of in vitro proliferation kinetics and primitive hematopoietic potential of individual human CD34+CD38-/lo cells in G0 . / Srour, Edward; Tong, Xia; Ki, Woong Sung; Plett, P. Artur; Rice, Susan; Daggy, Joanne; Yiannoutsos, Constantin; Abonour, Rafat; Orschell, Christie.

In: Blood, Vol. 105, No. 8, 15.04.2005, p. 3109-3116.

Research output: Contribution to journalArticle

@article{8ae0b014f0a94b06a736ed73793607f0,
title = "Modulation of in vitro proliferation kinetics and primitive hematopoietic potential of individual human CD34+CD38-/lo cells in G0",
abstract = "Whether cytokines can modulate the fate of primitive hematopoietic progenitor cells (HPCs) through successive in vitro cell divisions has not been established. Single human marrow CD34+CD38-/lo cells in the G0 phase of cell cycle were cultured under 7 different cytokine combinations, monitored for proliferation on days 3, 5, and 7, then assayed for long-term culture-initiating cell (LTC-IC) function on day 7. LTC-IC function was then retrospectively correlated with prior number of in vitro cell divisions to determine whether maintenance of LTC-IC function after in vitro cell division is dependent on cytokine exposure. In the presence of proliferation progression signals, initial cell division was independent of cytokine stimulation, suggesting that entry of primitive HPCs into the cell cycle is a stochastic property. However, kinetics of proliferation beyond day 3 and maintenance of LTC-IC function were sensitive to cytokine stimulation, such that LTC-IC underwent an initial long cell cycle, followed by more synchronized shorter cycles varying in length depending on the cytokine combination. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) transplantation studies revealed analogous results to those obtained with LTC-ICs. These data suggest that although exit from quiescence and commitment to proliferation might be stochastic, kinetics of proliferation, and possibly fate of primitive HPCs, might be modulated by extrinsic factors.",
author = "Edward Srour and Xia Tong and Ki, {Woong Sung} and Plett, {P. Artur} and Susan Rice and Joanne Daggy and Constantin Yiannoutsos and Rafat Abonour and Christie Orschell",
year = "2005",
month = "4",
day = "15",
doi = "10.1182/blood-2004-05-1773",
language = "English",
volume = "105",
pages = "3109--3116",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "8",

}

TY - JOUR

T1 - Modulation of in vitro proliferation kinetics and primitive hematopoietic potential of individual human CD34+CD38-/lo cells in G0

AU - Srour, Edward

AU - Tong, Xia

AU - Ki, Woong Sung

AU - Plett, P. Artur

AU - Rice, Susan

AU - Daggy, Joanne

AU - Yiannoutsos, Constantin

AU - Abonour, Rafat

AU - Orschell, Christie

PY - 2005/4/15

Y1 - 2005/4/15

N2 - Whether cytokines can modulate the fate of primitive hematopoietic progenitor cells (HPCs) through successive in vitro cell divisions has not been established. Single human marrow CD34+CD38-/lo cells in the G0 phase of cell cycle were cultured under 7 different cytokine combinations, monitored for proliferation on days 3, 5, and 7, then assayed for long-term culture-initiating cell (LTC-IC) function on day 7. LTC-IC function was then retrospectively correlated with prior number of in vitro cell divisions to determine whether maintenance of LTC-IC function after in vitro cell division is dependent on cytokine exposure. In the presence of proliferation progression signals, initial cell division was independent of cytokine stimulation, suggesting that entry of primitive HPCs into the cell cycle is a stochastic property. However, kinetics of proliferation beyond day 3 and maintenance of LTC-IC function were sensitive to cytokine stimulation, such that LTC-IC underwent an initial long cell cycle, followed by more synchronized shorter cycles varying in length depending on the cytokine combination. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) transplantation studies revealed analogous results to those obtained with LTC-ICs. These data suggest that although exit from quiescence and commitment to proliferation might be stochastic, kinetics of proliferation, and possibly fate of primitive HPCs, might be modulated by extrinsic factors.

AB - Whether cytokines can modulate the fate of primitive hematopoietic progenitor cells (HPCs) through successive in vitro cell divisions has not been established. Single human marrow CD34+CD38-/lo cells in the G0 phase of cell cycle were cultured under 7 different cytokine combinations, monitored for proliferation on days 3, 5, and 7, then assayed for long-term culture-initiating cell (LTC-IC) function on day 7. LTC-IC function was then retrospectively correlated with prior number of in vitro cell divisions to determine whether maintenance of LTC-IC function after in vitro cell division is dependent on cytokine exposure. In the presence of proliferation progression signals, initial cell division was independent of cytokine stimulation, suggesting that entry of primitive HPCs into the cell cycle is a stochastic property. However, kinetics of proliferation beyond day 3 and maintenance of LTC-IC function were sensitive to cytokine stimulation, such that LTC-IC underwent an initial long cell cycle, followed by more synchronized shorter cycles varying in length depending on the cytokine combination. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) transplantation studies revealed analogous results to those obtained with LTC-ICs. These data suggest that although exit from quiescence and commitment to proliferation might be stochastic, kinetics of proliferation, and possibly fate of primitive HPCs, might be modulated by extrinsic factors.

UR - http://www.scopus.com/inward/record.url?scp=17044390898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17044390898&partnerID=8YFLogxK

U2 - 10.1182/blood-2004-05-1773

DO - 10.1182/blood-2004-05-1773

M3 - Article

C2 - 15613542

AN - SCOPUS:17044390898

VL - 105

SP - 3109

EP - 3116

JO - Blood

JF - Blood

SN - 0006-4971

IS - 8

ER -